1 Min Read
* Says it receives patent about TSP-1, TSP-2, IL-17BR and hb-egf associated with stem cell activities and applications thereof
* Says patent number is 2013094776
Source text in Korean: goo.gl/hbA3oo
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.